Zeitungsständer (Symbolbild).
Dienstag, 12.04.2016 07:05 von GlobeNewswire | Aufrufe: 225

Clariant and South Korean BioSpectrum agree strategic partnership

Zeitungsständer (Symbolbild). © Global_Pics / iStock Unreleased / Getty Images

Clariant AG / Clariant and South Korean BioSpectrum agree strategic partnership . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

 

  • BioSpectrum is a leading provider of natural active ingredients for Personal Care with strong scientific capabilities in bioassay and claim substantiation
  • Clariant will become anchor shareholder and exclusive global distributor
  • Strategic partnership will combine Biospectrum's research strengths with Clariant's formulations expertise and global presence
 

 

Muttenz, April 12, 2016 - Clariant, a world leader in specialty chemicals, signed an agreement to acquire a 17 % share in BioSpectrum, Inc ("BioSpectrum"). Headquartered in South Korea, BioSpectrum is a leading developer and supplier of specialty active cosmetics' ingredients derived from Asia's diverse flora which have proven benefits for humans.

Currently a family-owned business, BioSpectrum will remain an independently managed company. Clariant will leverage its global sales and innovation network to market BioSpectrum's product portfolio of active ingredients worldwide, with the exception of Korea.

"The transaction will allow us to expand in the strategically important and growing global markets for Personal Care applications. Our investment in BioSpectrum will give us further access to highly innovative active ingredients based on renewable raw materials. This corresponds to a growing consumer demand for natural cosmetic ingredients, not only in the emerging markets of Asia but worldwide", said Hariolf Kottmann, CEO of Clariant.

Christian Vang, Head of Business Unit Industrial & Consumer Specialties (BU ICS) at Clariant, commented: "We are pleased about the strategic partnership with BioSpectrum. The transaction will further enhance our earlier investment in the partnership with Beraca in Latam America and leverages on our global customer platform through exclusive distributorship. This strategic investment strengthens and significantly enlarges Clariant's active ingredient portfolio, reinforcing our ability to deliver a comprehensive range of natural, sustainable and effective formulations to the Personal Care industry."

Dr. Deok-Hoon Park, CEO of BioSpectrum, added: "This partnership with Clariant will be a key step in BioSpectrum's growth. We will have a strong partner on-board supporting our fast and ambitious expansion plans and we foresee tremendous innovation synergies that will lead us to create more value for customers around the world."

BioSpectrum is renowned for its experience in researching and developing natural raw materials that can be used in skin and hair care products. The company has strong scientific capabilities in bioassay, efficacy testing and claim substantiation,which allows the design and development of high-quality actives ingredients for the cosmetics industry. All of the ingredients are based on state-of-the-art technology and have been widely tested and developed to meet the demands and trends of the cosmetics industry.

BioSpectrum's portfolio of functional ingredients is derived from natural products and extracts from exotic Asian plants, in particular those found on the South Korean Jeju Island - an isolated mountain formed by volcanic eruption and featuring over 1,800 plant species. Its formulation ingredients include active compounds offering moisturizing, whitening, anti-aging, wound healing, anti-acne, skin soothing, anti-inflammation, anti-dandruff, detoxification and body slimming effects.

Corporate Media Relations Investor Relations
Carsten Seum

Phone +41 61 469 63 63
carsten.seum@clariant.com
Anja Pomrehn

Phone +41 61 469 67 45
anja.pomrehn@clariant.com
Claudia Kamensky

Phone +41 61 469 63 63
claudia.kamensky@clariant.com
Steven Massheder

Phone +41 61 469 68 58
steven.massheder@clariant.com
gLOBAL tRADE MEDIA RELATIONS  
Stefanie Nehlsen

Phone +41 61 469 63 63
stefanie.nehlsen@clariant.com




This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Clariant AG via Globenewswire

HUG#2002542

--- End of Message ---

Clariant AG
Rothausstrasse 61 Muttenz 1 Switzerland

ISIN: CH0012142631;


ARIVA.DE Börsen-Geflüster

Werbung

Weiter aufwärts?

Kurzfristig positionieren in Clariant
MA3XET
Ask: 4,41
Hebel: 5,69
mit moderatem Hebel
Zum Produkt
Smartbroker
Morgan Stanley
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: MA3XET,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.

Kurse

13,42 CHF
+1,21%
Clariant Chart

Werbung

Mehr Nachrichten zur Clariant Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News